Clinical Trial Update: Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABT-869 (linifanib) with paclitaxel versus paclitaxel alone for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ABT-869 (linifanib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED